Clinical trials
Randomized Controlled Study clinical trials
Below are recruiting randomized controlled study clinical trials, each written for real people, not researchers. We’re tracking 482 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04065971RecruitingPhase 4
Test drug for frequent cold sores in the mouth
This trial tests whether 2LHERP® can reduce or manage frequent herpes infections around the mouth. It compares the study drug to a placebo (inactive treatment) in people who get many episodes each year.
BeerzelAges 16–80 - NCT06255392RecruitingPhase 3
Fluzoparib with apatinib vs chemo for advanced breast cancer
This trial tests a combination of two oral targeted drugs (fluzoparib and apatinib) against standard chemotherapy for women with advanced, HRD-positive, HER2-negative breast cancer. It may be an option if you have already received some treatments but not too many.
Guangzhou, GuangdongAges 18–70 - NCT07304791RecruitingPhase 1
Testing beam-103 safety in healthy volunteers
This trial tests a new drug called BEAM-103 in healthy people to see if it's safe and how the body processes it. It's a single-blind study, meaning you won't know if you get the drug or a placebo.
LondonAges 18–55 - NCT07762833RecruitingPhase 3
A study of an injectable treatment for moderate-to-severe eczema
This study tests a new injectable medicine (nemolizumab) for people with moderate-to-severe eczema that hasn't been helped enough by topical treatments. It aims to reduce itching and skin symptoms. The trial will compare the drug to a placebo in Chinese participants.
Hangzhou, ZhejiangAges 12 years+ - NCT07437911Recruiting
Can a Supplement Help with Nutrient Gaps for GLP-1 Users?
This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.
Santa Monica, CaliforniaAges 18–59 - NCT07345364RecruitingPhase 1
Safety of single dose SIM0811 in healthy adults
This trial tests a single dose of an investigational drug called SIM0811 in healthy Chinese adults. The goal is to see if it's safe and how the body processes it, so researchers can find the right dose for future studies.
Jinan, ShandongAges 18–45 - NCT07033026RecruitingPhase 2
Study of NGM120 for weight loss in colorectal cancer
This study tests an experimental drug called NGM120 for people with colorectal cancer who are losing weight (a condition called cancer cachexia). It is a placebo-controlled trial, meaning some participants will receive the drug and some will receive a placebo, to see if the drug helps stop or reverse this weight loss.
Los Angeles, CaliforniaAges 18 years+ - NCT06963606Recruiting
Using AI to find TB cases from chest X-rays
This study tests if a computer program that reads chest X-rays can help doctors find tuberculosis (TB) cases more effectively in community health clinics. If you have a cough or other breathing symptoms and are getting a chest X-ray, you may be able to join.
Yichang, HubeiAges 15 years+ - NCT07382830Recruiting
Visual feedback exercises after lower back surgery
This trial tests if a special exercise program that uses visual feedback helps people recover better after surgery for a herniated disc in the lower back. It may improve your recovery and reduce pain.
AntalyaAges 18–65 - NCT07143773RecruitingPhase 4
SGLT2i safety in kidney transplant patients without diabetes
This study tests whether a medicine called SGLT2i (a type of pill for kidney health) is safe and helpful for kidney transplant recipients who do not have diabetes. It aims to see if it can improve how the new kidney works.
OdenseAges 18 years+ - NCT05036590Recruiting
Testing a family support program for first-episode psychosis
This study checks whether a structured family intervention helps caregivers support a person with schizophrenia or a first psychotic episode. You may be asked to take part in a step-by-step program and answer questions to see if it works better than usual care.
BronAges 18 years+ - NCT06681649Recruiting
ICU follow-up care for survivors and their caregivers
This study tests a bundle of follow-up care for ICU survivors and their caregivers after leaving the hospital. It aims to improve recovery and support for both patients and their families.
Kingston, OntarioAges 18 years+ - NCT07377344Recruiting
Gum health care during pregnancy
This trial tests ways to improve gum health during pregnancy. If you have gum disease or are at risk, the study may provide dental care that could help both you and your baby.
San Francisco, CaliforniaAges 18 years+ - NCT07363538Recruiting
Comparing heart surgery methods for newborns with complex heart defects
This trial tests new surgical strategies for newborns with certain complex heart conditions. It aims to see which techniques lead to better recovery and quality of life in the first year after surgery.
Beijing, Beijing MunicipalityAges Up to 1 week - NCT05309460RecruitingPhase 4
Labetalol or nifedipine to treat postpartum high blood pressure
This study compares two common blood pressure medicines—labetalol and nifedipine—to control high blood pressure after childbirth. It may help you and your care team find the safest way to bring your blood pressure back to normal after delivery.
Omaha, NebraskaAges 19 years+ - NCT05047198RecruitingPhase 3
Catheter procedures to stop dangerous heart rhythm episodes
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
Ottawa, OntarioAges 55 years+ - NCT06674148RecruitingPhase 2/Phase 3
Qifangfeixian granules for connective tissue disease lung scarring
This trial tests a Chinese herbal medicine called Qifangfeixian granules for people with lung scarring (interstitial lung disease) related to connective tissue diseases (like lupus or scleroderma). It compares the medicine to a placebo to see if it helps improve breathing and lung function.
Wuhan, HubeiAges 18–80 - NCT06693362RecruitingPhase 1
Stem cell therapy for severe viral pneumonia
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07578064RecruitingPhase 4
Comparing two treatments for low white blood cells during breast cancer therapy
This study compares two medications—Shengbai Oral Liquid and Leucogen Tablets—to help raise white blood cell counts in breast cancer patients whose counts drop during cancer treatment. Both drugs aim to help your body recover faster and allow you to continue your cancer therapy on schedule.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06982963RecruitingPhase 2
Study of an experimental drug for celiac disease
This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.
MelbourneAges 18–70 - NCT07225751Recruiting
MagnetOs Bone Graft vs. Your Own Bone for Foot Fusion
This study tests a new bone graft material (MagnetOs) against using your own bone for hindfoot or ankle fusion surgery. The goal is to see if the new material works just as well for helping bones heal together.
Sacramento, CaliforniaAges 18–75 - NCT07852338RecruitingPhase 3
Placental graft for diabetic foot ulcers
This trial tests a treatment made from placental tissue, called Bioxheal, which is placed on a diabetic foot ulcer to help it heal. It compares this treatment to standard care alone.
Boardman, OhioAges 18 years+ - NCT07751302Recruiting
Follow-up vs. chemo after surgery for early stomach cancer
This trial compares two approaches after surgery for early-stage stomach or GEJ cancer: close monitoring (follow-up) vs. adjuvant chemotherapy (chemo given after surgery). It aims to see if follow-up alone is as good as chemo for patients with this stage, potentially avoiding chemo side effects.
Xi'an, ShaanxiAges 18 years+ - NCT07732023RecruitingPhase 1
Study of a new asthma medication compared to placebo
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Chengdu, SichuanAges 18–70
Hear when a new Randomized Controlled Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for randomized controlled study?
- Yes. Clin2 currently lists 482 recruiting randomized controlled study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a randomized controlled study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a randomized controlled study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.